Current results of the Robert Koch Institute show that a total of 7.2% of adults aged between 18 and 79 have been diagnosed with diabetes at some point in their lives. As compared to the "German National Health Interview and Examination Survey 1998" (GNHIES98), this represents a 2% increase in prevalence. A further 2.0 % of adults (1.3 million) have an undetected diabetes. According to the current state of knowledge, about 90 % of all diabetes cases can be attributed to type 2 diabetes.
Poorly controlled diabetes or diabetes which remains undiagnosed for a long period of time is associated with a higher risk of cardiovascular diseases, kidney malfunctions, blindness and foot amputations. These result in a reduced quality of life and life expectancy in affected persons as well as high costs for the health system.
Within the framework of health monitoring, the Robert Koch Institute continuously collects data on the prevalence of diabetes as well as of diabetes-specific complications and comorbidities. Associations with behaviour (such as diet, physical inactivity and associated overweight) and living conditions (such as personal and regional social factors) are investigated. In addition, markers of glucose metabolism are measured in the interview and examination surveys.
Within the framework of the research project "Establishment of a National Diabetes Surveillance" at the Robert Koch Institute, a regular indicator-based diabetes reporting based on primary data of the health monitoring at the Robert Koch Institute as well as on relevant secondary data at the federal and regional level is being developed.
Publications
Febrile seizures, epilepsy, migraine, diabetes, and heart disease as well as measles, chicken pox, and whooping cough in children and adolescents in Germany : Results from KiGGS Wave 2.Poethko-Müller C, Thamm R, Heidemann C, Busch M, Neuhauser H. Bundesgesundheitsbl 2019 62:1162–1173.
Secondary data in diabetes surveillance – co-operation projects and definition of references on the documented prevalence of diabetes.Schmidt C, Heidemann C, Rommel A, Brinks R, Claessen H, Dreß J, Hagen B, Hoyer A, Laux G, Pollmanns J, Präger M, Böhm J, Drösler S, Icks A, Kümmel S, Kurz C, Kvitkina T, Laxy M, Maier W, Narres M, Szecsenyi J, Tönnies T, Weyermann M, Paprott R, Reitzle L, Baumert J, Patelakis E, Ziese T. Journal of Health Monitoring 2019 4(2): 50-63. DOI 10.25646/5988
Diabetes at a glance – National diabetes surveillance.Schmidt C, Du Y, Baumert J, Reitzle L, Heidemann C, Paprott R, Ziese T, Scheidt-Nave C. Diabetologe. 2019 March, Volume 15, Issue 2, pp 120–127. doi.org/10.1007/s11428-018-0419-7
Diabetes Surveillance in Germany – Background, concept and prospectsGabrys L, Schmidt C, Heidemann C, Baumert J, Du Y, Paprott R, Teti A, Wolf IK, Ziese T, Scheidt-Nave C (2017) Journal of Health Monitoring 2(1). doi:10.17886/RKI-GBE-2017-022
Pregnancy risk factors for very premature delivery: what role do hypertension, obesity and diabetes play? (Abstract)Spiegler J, Stichtenoth G, Weichert J, König IR, Schlaud M, v.d. Wense A, Olbertz D, Gurth H, SchiffmannJH, Bohnhorst B, Gortner L, Herting E, Göpel W (2013) Archives of Gynecology and Obstetrics 288(1): 57-64. doi: 10.1007/s00404-013-2739-6